Skip to main content


Russell Broaddus, MD, PhD, is a co-leader for Project 1 and a co-director of the Biospecimens Core B. He chairs the Department of Pathology & Laboratory Medicine, UNC School of Medicine. He is currently the PI of Project 2 in the Endometrial Cancer SPORE based at University of Texas (UT) MDACC, which is currently in its third funding cycle. While at MDACC, he also served as the PI for the Pathology Cores for both the EC SPORE and the Ovarian Cancer SPORE.

As a gynecologic pathologist, he studies molecular mechanisms of endometrial cancer pathogenesis, particularly identifying novel molecular markers of recurrence risk and survival. His research group identified that CTNNB1 mutation was associated with shorter recurrence-free survival in EC patients with early stage, low grade endometrioid carcinomas.

For 15 years he served as the Co-Director for the MD/PhD Program jointly sponsored by UT-Houston Medical School and UT MDACC. He was the founding Director for the ACGME-approved Cancer Biomarker pathology fellowship. He was recently honored with the University of Texas Regents’ Outstanding Teacher Award, the highest teaching honor in the University of Texas System. Many of his former research trainees were gynecologic oncology fellows who now have faculty positions at MDACC, University of Chicago, University of Miami, and University of Oregon. Specifically relevant to this P20 RFA, Broaddus’ previous trainees have included Native Americans, African Americans and Hispanics.

Russell Broaddus headshot